Table 3. Cost per point change in secondary outcome results.
| Treatment groups | Mean cost | Mean effect | Bootstrap difference, mean incremental cost (95% CI) | Bootstrap difference, mean incremental effect (95% CI) | ICER |
| Years of full capability | |||||
| LAPs | £1937 | 2.326 | £533 (£52 to £983) | −0.006 (−0.092 to 0.0762 | Dominated |
| COCP | £2471 | 2.32 | |||
| EHP-30 pain domain score reduction | |||||
| LAPs | £1937 | 23.549 | £533 (£52 to £983) | −0.145 (−4.509 to 4.182 | Dominated |
| COCP | £2471 | 23.403 | |||
| Treatment failure avoided | |||||
| LAPs | £1937 | 0.166 | £533 (£52 to £983) | 0.039 (−0.035 to 0.113) | Dominated |
| COCP | £2471 | 0.205 | |||
COCPcombined oral contraceptivesEHP-30Endometriosis Health Profile 30ICERincremental cost-effectiveness ratioLAPslong-acting progestogens